Browse > Article
http://dx.doi.org/10.5385/jksn.2011.18.1.14

Disorders in Hemostasis  

Sung, Tae-Jung (Department of Pediatrics, College of Medicine, Hallym University)
Publication Information
Neonatal Medicine / v.18, no.1, 2011 , pp. 14-22 More about this Journal
Abstract
Neonatal bleeding is a common problem encountered in nursery rooms or neonatal intensive care units, especially among premature infants. Furthermore, owing to recent remarkable improvement of neonatology, survival rates of preterm neonates have increased; hence, neonatal bleeding cannot be emphasized enough. Since the total blood volume of neonates is small, bleeding can be one of the causes of morbidities and mortalities. Therefore, rapid diagnosis and immediate therapy is urgently needed. The patient's medical history including a familial history of a bleeding disorder or of a previously affected infant who suffered from bleeding along with maternal and neonatal drugs can provide important diagnostic clues. Presence of bleeding with or without petechiae and ecchymoses in a healthy term or late preterm infant with thrombocytopenia but normal prothrombin time and activated partial thromboplastin time strongly suggests a congenital bleeding disorder. For a sick infant who is bleeding from multiple sites, an acquired disorder such as disseminated intravascular coagulation is suspected. Intracranial hemorrhage in term or late preterm infants without a history of birth trauma is highly suggestive of coagulation disorders. The purpose of this review is to summarize recent advances in diagnostic methods is as well as basic concepts of neonatal hemostatic disorders. First, an outline of background information will be presented followed by a discussion of primary and secondary hemostatic disorders as well as inherited and acquired disorders.
Keywords
Hemostasis; Newborn; Hemorrhage; Congenital bleeding disorder; Acquired bleeding disorder;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8.   DOI
2 Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88:F359-64.   DOI
3 Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33: 52-65.   DOI   ScienceOn
4 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.   DOI
5 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
6 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
7 Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
8 Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia 2010;16 Suppl 5:168-75.
9 Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
10 Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55.   DOI   ScienceOn
11 Bussel JB, Sola-Visner M. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009;33:35-42.   DOI   ScienceOn
12 Kuhle S, Mitchell L, Massicotte P, Andrew M. Hemostatic disorders of the newborn. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2005:1145-79.
13 Choi JS, Kim SY, Ihm C, Kim SY. A case of neonatal alloimmune thrombocytopenia due to anti-HLA-B35. J Korean Soc Neonatol 2009;16:248-54.
14 Murphy MF, Bussel JB. Advances in the management of alloimmune thrombocytopenia. Br J Haematol 2007;136:366-78.   DOI   ScienceOn
15 Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009;7 Suppl 1:253-7.
16 Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.   DOI   ScienceOn
17 Bussel JB, McFarland JG, Berkowitz RL. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfus Med Rev 1990;4:149-62.   DOI   ScienceOn
18 Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8.   DOI   ScienceOn
19 Ljung RC. Prenatal diagnosis of haemophilia. Haemophilia 1999;5:84-7.   DOI   ScienceOn
20 Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001;112:264-74.   DOI   ScienceOn
21 Cox Gill J. Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin North Am 2004;18:1277-99.   DOI   ScienceOn
22 Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994;71:520-5.
23 Gazengel C, Fischer AM, Schlegel N, Rothschild C, Torchet MF, Dautzenberg MD, et al. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates. Nouv Rev Fr Hematol 1988;30:225-7.
24 Nichols WC, Ginsburg D. von Willebrand disease. Medicine (Baltimore) 1997;76:1-20.   DOI   ScienceOn
25 Rha JY, Kook JH, Kook H, Yang SJ, Cho D, Ryang DW, et al. Three cases of factor XI deficiency. Korean J Pediatr Hematol Oncol 2001; 8:344-8.
26 Kim HJ, Jung JH, Lee JH, Jo JD. A case of congenital factor VII deficiency associated with intraventricular hemorrhage and hydrocephalus. J Korean Pediatr Soc 1998;41:1726-30.
27 Cho KC, Lee SK, Kim IK, Sung H, Choi CH. A case of combined congenital deficiency of factor V and factor VIII. J Korean Pediatr Soc 1996;39:1162-7.
28 Townsend CW. The haemorrhagic disease of the newborn. Arch Pediatr 1894;11:559-65.
29 McNinch A. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom. Early Hum Dev 2010;86 Suppl 1:63- 5.
30 Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/ Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999;81:456-61.
31 Van Winckel M, De Bruyne R, Van De Velde S, Van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr 2009;168: 127-34.   DOI   ScienceOn
32 American Academy of Pediatrics, Committee on Nutrition. Pediatric nutrition handbook. 6th ed. Elk Grove Village: American Academy of Pediatrics, 2009:468-71.
33 Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane PA, et al. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 1986;109:675-80.   DOI
34 von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization, Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993;69:293-5.
35 Schubiger G, Stocker C, Bänziger O, Laubscher B, Zimmermann H. Oral vitamin K1 prophylaxis for newborns with a new mixedmicellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999;158:599-602.   DOI   ScienceOn
36 Clark FI, James EJ. Twenty-seven years of experience with oral vitamin K1 therapy in neonates. J Pediatr 1995;127:301-4.   DOI   ScienceOn
37 Vietti TJ, Murphy T, James JA, Pritchard JA. Observation on the prophylactic use of vitamin K in the newborn. J Pediatr 1960;56: 343-6.   DOI
38 Cornelissen EA, Kollee LA, De Abreu RA, Motohara K, Monnens LA. Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr 1993;82:656-99.
39 Lippi G, Franchini M. Vitamin K in neonates: facts and myths. Blood Transfus 2011;9:4-9.
40 Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002;8:1-31.   DOI   ScienceOn
41 Veldman A, Fischer D, Nold MF, Wong FY. Disseminated intravascular coagulation in term and preterm neonates. Semin Thromb Hemost 2010;36:419-28.   DOI   ScienceOn
42 Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.   DOI   ScienceOn
43 Kreuz W, Veldmann A, Fischer D, Schlosser R, Volk WR, Ettingshausen CE. Neonatal sepsis: a challenge in hemostaseology. Semin Thromb Hemost 1999;25:531-5.   DOI
44 von Kries R, Stannigel H, Göbel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 1985;144:191-4.   DOI   ScienceOn
45 Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:470-6.   DOI   ScienceOn
46 Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-8.   DOI   ScienceOn
47 Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006;118:123-35.   DOI   ScienceOn
48 Newall F, Johnston L, Ignjatovic V, Monagle P. Unfractionated heparin therapy in infants and children. Pediatrics 2009;123:e510-8.   DOI   ScienceOn
49 Martchenke J, Boshkov L. Heparin-induced thrombocytopenia in neonates. Neonatal Netw 2005;24:33-7.